{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:11:15Z","timestamp":1767773475225},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,8]]},"DOI":"10.7759\/cureus.13768","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T17:58:01Z","timestamp":1615226281000},"source":"Crossref","is-referenced-by-count":3,"title":["Pembrolizumab-Induced Lichenoid Dermatitis in a Patient With Metastatic Cancer of Unknown Primary"],"prefix":"10.7759","author":[{"given":"Ashish","family":"Sethi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Keytruda. PD-1 receptor blockade. (2021). https:\/\/www.keytruda.com\/hcp\/mechansim-of-action\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12899","article-title":"Extramedullary hematopoiesis in mismatch repair deficient colon cancer patient on adjuvant chemotherapy","volume":"13","author":"De Leo EK","year":"2021","unstructured":"De Leo EK, Shah CP, Grajo JR, et al.. Extramedullary hematopoiesis in mismatch repair deficient colon cancer patient on adjuvant chemotherapy. Cureus. 2021, 13:e12899. 10.7759\/cureus.12899","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.04524.x","article-title":"Mechanisms of cutaneous drug reactions [Article in German]","volume":"2","author":"Yawalkar N","year":"2004","unstructured":"Yawalkar N, Pichler WJ.  Mechanisms of cutaneous drug reactions [Article in German]. J Dtsch Dermatol Ges. 2004, 2:1013-1023. 10.1046\/j.1439-0353.2004.04524.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref4","article-title":"Pravastatin-induced lichenoid drug eruption","volume":"61","author":"Keough GC","year":"1998","unstructured":"Keough GC, Richardson TT, Grabski WJ. Pravastatin-induced lichenoid drug eruption. Cutis. 1998, 61:98-100.","journal-title":"Cutis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70176-t","article-title":"Lichenoid drug eruptions","volume":"29","author":"Halevy S","year":"1993","unstructured":"Halevy S, Shai A.  Lichenoid drug eruptions. J Am Acad Dermatol.  1993, 29:249-255. 10.1016\/0190-9622(93)70176-t","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0134","article-title":"Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy","volume":"3","author":"Joseph RW","year":"2015","unstructured":"Joseph RW, Cappel M, Goedjen B, et al.. Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy. Cancer Immunol Res. 2015, 3:18-22. 10.1158\/2326-6066.CIR-14-0134","journal-title":"Cancer Immunol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2218-6751.2015.06.06","article-title":"Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities","volume":"4","author":"Villadolid J","year":"2015","unstructured":"Villadolid J, Amin A. Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities.  Transl Lung Cancer Res. 2015, 4:560-575. 10.3978\/j.issn.2218-6751.2015.06.06","journal-title":"Transl Lung Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont AM","year":"2015","unstructured":"Eggermont AM, Chiarion-Sileni V, Grob JJ\r\n. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015, 16:522-530. 10.1016\/S1470-2045(15)70122-1","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi FS","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al.. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010, 363:711-723. 10.1056\/NEJMoa1003466","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5759-1","article-title":"Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma","author":"Cardis M.A","year":"2019","unstructured":"Cardis M.A, Jiang H, Strauss J, et al..  Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma. BMC Cancer. 2019, 539. 10.1186\/s12885-019-5759-1","journal-title":"BMC Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2011.02.009","article-title":"Evidence-based skin care management in radiation therapy: clinical update","volume":"27","author":"McQuestion M","year":"2011","unstructured":"McQuestion M. Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs. 2011, 27:e1-e17. 10.1016\/j.soncn.2011.02.009","journal-title":"Semin Oncol Nurs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/53339-pembrolizumab-induced-lichenoid-dermatitis-in-a-patient-with-metastatic-cancer-of-unknown-primary","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:28Z","timestamp":1707507028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/53339-pembrolizumab-induced-lichenoid-dermatitis-in-a-patient-with-metastatic-cancer-of-unknown-primary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.13768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}